Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Delft IMP
Netherlands
- Delft, South Holland
- 06/10/2021
- Series A
- $10,000,000
Delft IMP offers research & development services and licensing of IP on scalable production of nanostructured materials based on atomic layer deposition (ALD).
ALD is a chemical deposition method to obtain conformal coatings of controllable thickness on many types of substrate. Together with the Delft IMP intellectual property and know-how on scalable production of nanostructured materials, this allows for efficient precursor use for catalysts, encapsulation of battery particles for improved durability, controlled release of medication, and many more applications.
Don't hesitate to contact us on info@delft-imp.nl for more information.
- Industry Nanotechnology Research
- Website https://delft-imp.nl/
- LinkedIn https://www.linkedin.com/company/delft-imp-b-v-/
Related People
Roderik ColenFounder
Netherlands -
The Hague, South Holland,
Executive with 20 years’ experience in the energy sector. I enjoy executing business strategies, leading supply chains whilst focusing on what organisations need to have the highest impact.
Strong interpersonal skills, a collaborative style and natural curiosity, enable me to communicate well at all levels within an organisation and with customers and stakeholders. My drive and enthusiasm make the difference.
My career ambition is to lead a start/scale up whilst being board member in larger cleantech and NGO related organisations.
Additional functions/memberships: Board Member National Dutch Food-bank Association
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)